PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-67

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    Agree.

    Whatever it is - it would have been worked out by now....just waiting on EMA approval.

    No CRO would take on a large, multi national project like this without some reassurance about funding.

    I'm leaning towards Pharma partnership, cornerstone investment, and a seat on the Board to go with it.

    This will give ANP the $$$ to pursue new indications.

    All will be revealed soon.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.